Cargando…
Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris
Cone snails produce a fast-acting and often paralyzing venom, largely dominated by disulfide-rich conotoxins targeting ion channels. Although disulfide-poor conopeptides are usually minor components of cone snail venoms, their ability to target key membrane receptors such as GPCRs make them highly v...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143535/ https://www.ncbi.nlm.nih.gov/pubmed/32155768 http://dx.doi.org/10.3390/md18030150 |
_version_ | 1783519635185860608 |
---|---|
author | Giribaldi, Julien Ragnarsson, Lotten Pujante, Tom Enjalbal, Christine Wilson, David Daly, Norelle L. Lewis, Richard J. Dutertre, Sebastien |
author_facet | Giribaldi, Julien Ragnarsson, Lotten Pujante, Tom Enjalbal, Christine Wilson, David Daly, Norelle L. Lewis, Richard J. Dutertre, Sebastien |
author_sort | Giribaldi, Julien |
collection | PubMed |
description | Cone snails produce a fast-acting and often paralyzing venom, largely dominated by disulfide-rich conotoxins targeting ion channels. Although disulfide-poor conopeptides are usually minor components of cone snail venoms, their ability to target key membrane receptors such as GPCRs make them highly valuable as drug lead compounds. From the venom gland transcriptome of Conus miliaris, we report here on the discovery and characterization of two conopressins, which are nonapeptide ligands of the vasopressin/oxytocin receptor family. These novel sequence variants show unusual features, including a charge inversion at the critical position 8, with an aspartate instead of a highly conserved lysine or arginine residue. Both the amidated and acid C-terminal analogues were synthesized, followed by pharmacological characterization on human and zebrafish receptors and structural investigation by NMR. Whereas conopressin-M1 showed weak and only partial agonist activity at hV1bR (amidated form only) and ZFV1a1R (both amidated and acid form), both conopressin-M2 analogues acted as full agonists at the ZFV2 receptor with low micromolar affinity. Together with the NMR structures of amidated conopressins-M1, -M2 and -G, this study provides novel structure-activity relationship information that may help in the design of more selective ligands. |
format | Online Article Text |
id | pubmed-7143535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71435352020-04-14 Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris Giribaldi, Julien Ragnarsson, Lotten Pujante, Tom Enjalbal, Christine Wilson, David Daly, Norelle L. Lewis, Richard J. Dutertre, Sebastien Mar Drugs Article Cone snails produce a fast-acting and often paralyzing venom, largely dominated by disulfide-rich conotoxins targeting ion channels. Although disulfide-poor conopeptides are usually minor components of cone snail venoms, their ability to target key membrane receptors such as GPCRs make them highly valuable as drug lead compounds. From the venom gland transcriptome of Conus miliaris, we report here on the discovery and characterization of two conopressins, which are nonapeptide ligands of the vasopressin/oxytocin receptor family. These novel sequence variants show unusual features, including a charge inversion at the critical position 8, with an aspartate instead of a highly conserved lysine or arginine residue. Both the amidated and acid C-terminal analogues were synthesized, followed by pharmacological characterization on human and zebrafish receptors and structural investigation by NMR. Whereas conopressin-M1 showed weak and only partial agonist activity at hV1bR (amidated form only) and ZFV1a1R (both amidated and acid form), both conopressin-M2 analogues acted as full agonists at the ZFV2 receptor with low micromolar affinity. Together with the NMR structures of amidated conopressins-M1, -M2 and -G, this study provides novel structure-activity relationship information that may help in the design of more selective ligands. MDPI 2020-03-06 /pmc/articles/PMC7143535/ /pubmed/32155768 http://dx.doi.org/10.3390/md18030150 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Giribaldi, Julien Ragnarsson, Lotten Pujante, Tom Enjalbal, Christine Wilson, David Daly, Norelle L. Lewis, Richard J. Dutertre, Sebastien Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris |
title | Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris |
title_full | Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris |
title_fullStr | Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris |
title_full_unstemmed | Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris |
title_short | Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris |
title_sort | synthesis, pharmacological and structural characterization of novel conopressins from conus miliaris |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143535/ https://www.ncbi.nlm.nih.gov/pubmed/32155768 http://dx.doi.org/10.3390/md18030150 |
work_keys_str_mv | AT giribaldijulien synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris AT ragnarssonlotten synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris AT pujantetom synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris AT enjalbalchristine synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris AT wilsondavid synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris AT dalynorellel synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris AT lewisrichardj synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris AT dutertresebastien synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris |